We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth (UNH) Counting on Optum for Long-Term Growth
Read MoreHide Full Article
UnitedHealth Group Inc. (UNH - Free Report) is now banking on its health services business Optum for growth. This decision follows stringent regulatory restrictions imposed by the health care reform in 2010 that hit its health benefits business which provides health insurance products.
Optum is a health services business serving the broad health care marketplace and a major part of the company’s diversification strategy. It incepted from the joining of the company’s health services business into one segment in 2011 and comprises OptumHealth, OptumInsight and OptumRx. UnitedHealth’s fast growing health services business will fuel long-term growth and be a key differentiator.
Since 2011, Optum has compounded revenues at 23% per year and operating earnings at 34% every year. In 2015, Optum grew its revenues by 42% (including the acquisition of Catamaran in July) and its contract backlog by more than 20%. We expect OptumHealth, OptumInsight and OptumRx to continue producing strong, sustainable growth across the board in 2016 and beyond, as a leader in the U.S. and international health services markets estimated at $1.0 trillion in the aggregate.
The company has grown this segment through a number of acquisitions. Some of the significant takeovers include that of Audax Health Solutions, Inc. in 2014 as well as Irvine-based Monarch HealthCare and care and care management services provider Inspiris in 2011.
In 2015, Optum joined forces with MedExpress, a leader in high quality, affordable walk-in care, to expand access to lower-cost services in communities nationwide. It also acquired AxelaCare Health Solutions, a leading provider of home infusion solutions.
One of the biggest acquisitions made by the company under this segment was that of Catamaan Corp., for $12.8 billion, last year. It bolstered Optum’s pharmacy business.
Management is considering the expansion of the health service business to generate 30–40% of operating income over the longer term and has been making acquisitions in the area. Moreover, management feels that the company is under-penetrated in the health service area and that investments in this field will reap benefits over the long term.
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
UnitedHealth (UNH) Counting on Optum for Long-Term Growth
UnitedHealth Group Inc. (UNH - Free Report) is now banking on its health services business Optum for growth. This decision follows stringent regulatory restrictions imposed by the health care reform in 2010 that hit its health benefits business which provides health insurance products.
Optum is a health services business serving the broad health care marketplace and a major part of the company’s diversification strategy. It incepted from the joining of the company’s health services business into one segment in 2011 and comprises OptumHealth, OptumInsight and OptumRx.
UnitedHealth’s fast growing health services business will fuel long-term growth and be a key differentiator.
Since 2011, Optum has compounded revenues at 23% per year and operating earnings at 34% every year. In 2015, Optum grew its revenues by 42% (including the acquisition of Catamaran in July) and its contract backlog by more than 20%. We expect OptumHealth, OptumInsight and OptumRx to continue producing strong, sustainable growth across the board in 2016 and beyond, as a leader in the U.S. and international health services markets estimated at $1.0 trillion in the aggregate.
UNITEDHEALTH GP Price
UNITEDHEALTH GP Price | UNITEDHEALTH GP Quote
The company has grown this segment through a number of acquisitions. Some of the significant takeovers include that of Audax Health Solutions, Inc. in 2014 as well as Irvine-based Monarch HealthCare and care and care management services provider Inspiris in 2011.
In 2015, Optum joined forces with MedExpress, a leader in high quality, affordable walk-in care, to expand access to lower-cost services in communities nationwide. It also acquired AxelaCare Health Solutions, a leading provider of home infusion solutions.
One of the biggest acquisitions made by the company under this segment was that of Catamaan Corp., for $12.8 billion, last year. It bolstered Optum’s pharmacy business.
Management is considering the expansion of the health service business to generate 30–40% of operating income over the longer term and has been making acquisitions in the area. Moreover, management feels that the company is under-penetrated in the health service area and that investments in this field will reap benefits over the long term.
UnitedHealth carries a Zacks Rank #2 (Buy). Other stocks worth considering include The Joint Corp. (JYNT - Free Report) , WellCare Health Plans, Inc. and Nobilis Health Corp. (HLTH - Free Report) . Each of these stocks carries the same Zacks Rank as UnitedHealth. You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>